Group One Trading’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.4K Buy
2,500
+1,800
+257% +$34K ﹤0.01% 5305
2025
Q4
$10.3K Buy
+700
New +$11.2K ﹤0.01% 6796

Other funds holding MRNY

Group One Trading's MRNY Position: Q1 2026 in Review

Group One Trading increased its YieldMax MRNA Option Income Strategy ETF (MRNY) stake by 621% in Q1 2026, buying an estimated $26.5K and bringing the position to 1,629 shares worth $30.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5665.

Group One Trading first reported a position in MRNY in Q4 2024 and has held it in 6 quarters since. The position peaked at $37.8K in Q2 2025. 11 funds tracked by Wall St. Rank hold MRNY as of Q1 2026.

  • Group One Trading held 1,629 shares of YieldMax MRNA Option Income Strategy ETF worth $30.3K as of Q1 2026.
  • Group One Trading bought 1,403 YieldMax MRNA Option Income Strategy ETF shares in Q1 2026, an estimated $26.5K.
  • YieldMax MRNA Option Income Strategy ETF made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5665 holding.
  • Group One Trading first reported a position in YieldMax MRNA Option Income Strategy ETF in Q4 2024 and has held it in 6 quarters since.
  • Group One Trading's YieldMax MRNA Option Income Strategy ETF position peaked at $37.8K in Q2 2025.
  • 11 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.